📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

29.7 mL/min

Poorly Dialyzable

Minimal removal expected. Half-life: 5.2 hours. No supplementation needed.

Data Used:
✅ protein_binding, molar_mass, mw_factor, vd, vd_factor, half_life

Free fraction: 0.55 Mw factor: 1 Vd factor: 0.2 Hl factor: 1 Half life: 5.2 hours Half life category: Intermediate (4-12h)

🫀

3.0 mL/min

Low PD Clearance

Minimal removal expected. No supplementation needed. Half-life: 5.2 hours.

Data Used:
✅ protein_binding, molar_mass, half_life

Free fraction: 0.55 Half life: 5.2 hours Half life category: Intermediate (4-12h)

🔄

Low Risk

This drug is unlikely to be significantly removed by TPE.

Data Used:
✅ protein_binding, vd, half_life

Half life: 5.2 hours Half life category: Intermediate (4-12h)

🧪

Low Effectiveness

Poor candidate for hemoperfusion. Drug is distributed in tissues.

Data Used:
✅ vd, half_life

Half life: 5.2 hours Half life category: Intermediate (4-12h)

Modality	Clearance/Value	Half-Life	Classification	Data Quality
Hemodialysis	29.7 mL/min	5.2 hours	Poorly Dialyzable	Complete Data
Peritoneal Dialysis	3.0 mL/min	5.2 hours	Low PD Clearance	Complete Data
Plasmapheresis (TPE)	Low Risk	5.2 hours	N/A	Complete Data
Hemoadsorption	Low Effectiveness	5.2 hours	N/A	Complete Data

Hemodialysis: Estimates based on high-flux dialyzer (urea clearance 270 mL/min), Qb 300 mL/min, 4-hour session.
Peritoneal Dialysis: Estimates based on CAPD (Continuous Ambulatory Peritoneal Dialysis).
TPE: Risk assessment based on protein binding and volume of distribution.
Hemoadsorption: Effectiveness based on volume of distribution. Most effective for drugs with Vd < 0.2 L/kg.
Data Quality: Estimates with missing data use default assumptions. Consider adding missing data for more accurate predictions.
Clinical Note: These are descriptive estimates only. Always consult clinical guidelines and monitor drug levels when available.